To determine the suitability of mouse models of disease for therapeutic trials, the models must be characterised to determine their similarity to the human condition, and utility for specific therapeutic approaches. The YAC128 mouse model of HD has been bred on to C57BL/6J background in order to provide a mouse model of the disease better suited to behavioural testing, than the visually impaired original line on the FVB background. In the present study, the C57BL/6J YAC128 mice were assessed on several behavioural tasks bi-monthly between 4 and 24 months of age. On the rotarod early and stable deficits were demonstrated in the YAC128 mice from 4 months of age indicating an early abnormality in motor coordination. Early and stable deficits w...
The longitudinal characterisation of Huntington's disease (HD) mouse lines is essential for the unde...
In people with Huntington's disease, an expanded CAG repeat sequence on the HTT gene confers a toxic...
Transgenic mice expressing exon 1 of the human Huntington's disease (HD) gene carrying a 141-157 CAG...
To determine the suitability of mouse models of disease for therapeutic trials, the models must be c...
To determine the suitability of mouse models of disease for therapeutic trials, the models must be c...
Huntington's disease is caused by a single mutation on the HTT gene which produces an expansion in t...
Huntington's disease is caused by a single mutation on the HTT gene which produces an expansion in t...
Huntington's disease is caused by a single mutation on the HTT gene which produces an expansion in t...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
The longitudinal characterisation of Huntington's disease (HD) mouse lines is essential for the unde...
The longitudinal characterisation of Huntington's disease (HD) mouse lines is essential for the unde...
The longitudinal characterisation of Huntington's disease (HD) mouse lines is essential for the unde...
In people with Huntington's disease, an expanded CAG repeat sequence on the HTT gene confers a toxic...
Transgenic mice expressing exon 1 of the human Huntington's disease (HD) gene carrying a 141-157 CAG...
To determine the suitability of mouse models of disease for therapeutic trials, the models must be c...
To determine the suitability of mouse models of disease for therapeutic trials, the models must be c...
Huntington's disease is caused by a single mutation on the HTT gene which produces an expansion in t...
Huntington's disease is caused by a single mutation on the HTT gene which produces an expansion in t...
Huntington's disease is caused by a single mutation on the HTT gene which produces an expansion in t...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
The longitudinal characterisation of Huntington's disease (HD) mouse lines is essential for the unde...
The longitudinal characterisation of Huntington's disease (HD) mouse lines is essential for the unde...
The longitudinal characterisation of Huntington's disease (HD) mouse lines is essential for the unde...
In people with Huntington's disease, an expanded CAG repeat sequence on the HTT gene confers a toxic...
Transgenic mice expressing exon 1 of the human Huntington's disease (HD) gene carrying a 141-157 CAG...